(12) United States Patent (10) Patent No.: US 9.447,114 B2 Chenard Et Al
USOO94471.14B2 (12) United States Patent (10) Patent No.: US 9.447,114 B2 Chenard et al. (45) Date of Patent: Sep. 20, 2016 (54) THIENO- AND 2015,0111038 A1* 4, 2015 Kadam ................ CO7D 495/04 FURO2,3-DIPYRIMIDINE-2,41H,3H-DIONE 2015,0190366 A1* 7, 2015 Hous Agik ; : DERVATIVES OuSley ............... 5.14?6.5 2016/0046624 A1 2/2016 Chenard .............. CO7D 471/04 (71) Applicant: Hydra Biosciences, Inc., Cambridge, 514,264.1 MA (US) FOREIGN PATENT DOCUMENTS (72) Inventors: Bertrand L. Chenard, Waterford, CT (US); Randall J. Gallaschun, Lebanon, JP EP 0640606 A1 * 3, 1995 ........... A61K 31.505 WO WO O2O64572 A1 * 8, 2002 ... A64K 31,517 CT (US) WO WO-2004O28634 A1 4/2004 WO WO-2008070529 A2 6, 2008 (73) Assignee: Hydra Biosciences, Inc., Cambridge, WO WO-2010017368 A2 2, 2010 MA (US) OTHER PUBLICATIONS (*) Notice: Subject to any disclaimer, the term of this CAS Registry No. 606122-61-6 (Entered STN: Oct. 17, 2003).* patent is extended or adjusted under 35 CAS Registry No. 1497903-60-2 (Entered STN: Dec. 18, 2013).* U.S.C. 154(b) by 0 days. CAS Registry Nos. (Indexed 2012).* CAS Registry Nos. (Indexed 2006).* (21) Appl. No.: 14/822,018 C. Hong et al., 138 Brain, 3030-3047 (2015).* K.D. Phelan et al., 83 Molecular Pharmacology, 429–438 (2013).* (22) Filed: Aug. 10, 2015 M. Raychaudhuri et al., 2011 International Journal of Alzheimer's Disease, 1-5 (2011).* (65) Prior Publication Data J. Richter et al., 171 British Journal of Pharmacology, 158-170 (2014).* US 2016/OO398.41 A1 Feb.
[Show full text]